Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. 2010

Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente, Pasadena, CA 91101, USA. Hung-Fu.x.Tseng@kp.org

BACKGROUND Previous studies of varicella-zoster virus reactivation in children have provided little information on potential risk factors. The aim of this study was to investigate the effects of race, chronic medical conditions and treatments, and recent vaccination, on the risk of herpes zoster (HZ) in children vaccinated with one dose of varicella vaccine. METHODS Case subjects were identified from a cohort of subjects who were members of the Southern California Kaiser Permanente Health Plan and received primary immunization with a single-antigen live varicella vaccine at age < or = 12 years from 2002 to 2008. Control subjects free of HZ during the study period were matched at a 5:1 ratio to each case subject on date of birth and sex. Race information was obtained from membership files, health records, and phone interview. Immunization history, medical history, and health care utilization were identified from Southern California Kaiser Permanente Health Plan electronic records. RESULTS During this time, 122 children were diagnosed with HZ. With adjustment for the number of hospitalizations, outpatient visits, and length of time between vaccination with varicella vaccine and the onset of HZ, Black children were at lower risk of developing HZ than were White (OR=0.41, 95% CI=0.17-0.98) and Asian children (OR=0.30, 95% CI=0.11-0.84). CONCLUSIONS These data suggest that the racial differences in the risk of developing HZ seen in adults are manifest in children as well. As children are not subject to the majority of factors hypothesized to underlie HZ in adults and as this study was conducted in a setting which affords equal access to health care, it is possible that genetic variation may explain some portion of varicella-zoster virus reactivation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002140 California State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus

Related Publications

Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
February 2000, The Pediatric infectious disease journal,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
March 2008, The Journal of infectious diseases,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
February 2001, The Pediatric infectious disease journal,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
May 2022, Journal of diabetes and its complications,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
September 2012, Cutis,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
January 2022, RMD open,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
November 2020, Journal of child neurology,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
March 1961, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
January 1986, Pediatrics,
Hung Fu Tseng, and Ning Smith, and S Michael Marcy, and Lina S Sy, and Chun R Chao, and Steven J Jacobsen
October 1999, The Journal of reproductive medicine,
Copied contents to your clipboard!